First test of new spinal injury drug begins in humans
Disease control
Completed
This was an early-stage study to check the safety of a new drug called ALMB-0166 in people with a recent spinal cord injury. It involved 24 patients who received either the drug or a placebo. The main goal was to see if the drug was safe and to understand how the body absorbs and…
Phase: PHASE1 • Sponsor: AlaMab Therapeutics (Shanghai) Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC